AR and ovarian cancer: As CHST11 and CSA upregulation has been observed in multiple cancers not associated with AR signaling, including breast, lung, colorectal, and ovarian cancer patients52,78, there are likely other mechanisms of CHST11 and CSA regulation remaining to be elucidated.